Blood test may predict chemo side effects in brain cancer patients
NCT ID NCT02617745
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study looked at 244 people with glioblastoma, a serious brain cancer, to see if changes in platelet counts during early treatment could predict later blood problems. The goal was to create a monitoring plan to catch low platelet levels early. The study did not test a new treatment, but aimed to improve safety during standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Henri Becquerel
Rouen, 76038, France
Conditions
Explore the condition pages connected to this study.